Multiple Assemblies exist for SMTL entry 5tca
Complement Factor D inhibited with JH3; X-RAY DIFFRACTION 3.15 Å

	SMTL ID 5tca.1 Ligands 1-(2-{(2S)-2-[(6-bromopyridin-2-yl)carbamoyl]-1,3-thiazolidin-3-yl}-2-oxoethyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamide Polypeptides Complement factor D Oligo-state monomer
	SMTL ID 5tca.2 Ligands 1-(2-{(2S)-2-[(6-bromopyridin-2-yl)carbamoyl]-1,3-thiazolidin-3-yl}-2-oxoethyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamide Polypeptides Complement factor D Oligo-state monomer
	SMTL ID 5tca.3 Ligands 1-(2-{(2S)-2-[(6-bromopyridin-2-yl)carbamoyl]-1,3-thiazolidin-3-yl}-2-oxoethyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamide Polypeptides Complement factor D Oligo-state monomer
	SMTL ID 5tca.4 Ligands 1-(2-{(2S)-2-[(6-bromopyridin-2-yl)carbamoyl]-1,3-thiazolidin-3-yl}-2-oxoethyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamide Polypeptides Complement factor D Oligo-state monomer
	SMTL ID 5tca.5 Ligands 1-(2-{(2S)-2-[(6-bromopyridin-2-yl)carbamoyl]-1,3-thiazolidin-3-yl}-2-oxoethyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamide Polypeptides Complement factor D Oligo-state monomer
	SMTL ID 5tca.6 Ligands 1-(2-{(2S)-2-[(6-bromopyridin-2-yl)carbamoyl]-1,3-thiazolidin-3-yl}-2-oxoethyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamide Polypeptides Complement factor D Oligo-state monomer
	SMTL ID 5tca.7 Ligands 1-(2-{(2S)-2-[(6-bromopyridin-2-yl)carbamoyl]-1,3-thiazolidin-3-yl}-2-oxoethyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamide Polypeptides Complement factor D Oligo-state monomer